Intravesical Bacillus Calmette-Guerin Therapy for Grade 3 Non-Muscle Invasive Bladder Cancer: Results of Six or Eight Successive Instillations

Publisher： Karger

E-ISSN： 1661-7657|5|1|41-45

ISSN： 1661-7649

Source： Current Urology, Vol.5, Iss.1, 2011-03, pp. : 41-45

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non‐muscle invasive bladder cancer and bacillus Calmette‐Guerin treatment: a review of the literature

By  

INTERNATIONAL JOURNAL OF UROLOGICAL NURSING, Vol. 9, Iss. 2, 2015-07 ,pp. : 57-68

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Moreau Strain of Bacillus Calmette-Guerin (BCG) for High-Risk Non-Muscle Invasive Bladder Cancer: An Alternative during Worldwide BCG Shortage?

By  

Urologia Internationalis, Vol. 96, Iss. 1, 2016-0 ,pp. : 46-50

Karger

Access to resources Recommend Favorite

Contemporary cost‐effectiveness analysis comparing sequential bacillus Calmette‐Guerin and electromotive mitomycin versus bacillus Calmette‐Guerin alone for patients with high‐risk non–muscle‐invasive bladder cancer

By  

CANCER, Vol. 120, Iss. 16, 2014-08 ,pp. : 2424-2431

John Wiley & Sons Inc

Access to resources Recommend Favorite

Non Muscle Invasive Bladder Cancer Cases Initially Failing to Respond to Bacillus Calmette-Guérin Intravesical Instillation Therapy

By  

Current Urology, Vol. 4, Iss. 1, 2010-01 ,pp. : 18-24

Karger

Access to resources Recommend Favorite

Intravesical bacillus Calmette–Guérin instillation in non‐muscle‐invasive bladder cancer: A review

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 25, Iss. 1, 2018-01 ,pp. : 18-24

John Wiley & Sons Inc

Access to resources Recommend Favorite